These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9412162)

  • 1. [Premenstrual dysphoric disorder: long-term treatment with fluoxetine and discontinuation].
    de la Gándara Martín JJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(4):235-42. PubMed ID: 9412162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
    Silber TJ; Valadez-Meltzer A
    J Adolesc Health; 2005 Dec; 37(6):518-25. PubMed ID: 16310133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating premenstrual dysphoric disorder using serotonin agents.
    Lin J; Thompson DS
    J Womens Health Gend Based Med; 2001 Oct; 10(8):745-50. PubMed ID: 11703886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.
    Atmaca M; Kumru S; Tezcan E
    Hum Psychopharmacol; 2003 Apr; 18(3):191-5. PubMed ID: 12672170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
    Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
    Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
    Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
    Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSRIs for premenstrual dysphoric disorder.
    Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
    Pearlstein TB; Halbreich U; Batzar ED; Brown CS; Endicott J; Frank E; Freeman EW; Harrison WM; Haskett RF; Stout AL; Yonkers KA
    J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine in the treatment of premenstrual dysphoric disorder.
    Carr RR; Ensom MH
    Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.
    Steiner M; Korzekwa M; Lamont J; Wilkins A
    Psychopharmacol Bull; 1997; 33(4):771-4. PubMed ID: 9493491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
    Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
    Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
    Pearlstein TB; Stone AB; Lund SA; Scheft H; Zlotnick C; Brown WA
    J Clin Psychopharmacol; 1997 Aug; 17(4):261-6. PubMed ID: 9241004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
    Pearlstein T; Yonkers KA
    Expert Opin Pharmacother; 2002 Jul; 3(7):979-91. PubMed ID: 12083997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
    Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
    Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
    Steiner M; Pearlstein T
    J Clin Psychiatry; 2000; 61 Suppl 12():17-21. PubMed ID: 11041380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder.
    Hunter MS; Ussher JM; Browne SJ; Cariss M; Jelley R; Katz M
    J Psychosom Obstet Gynaecol; 2002 Sep; 23(3):193-9. PubMed ID: 12436805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
    Luisi AF; Pawasauskas JE
    Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.
    Rendas-Baum R; Yang M; Gricar J; Wallenstein GV
    Appl Health Econ Health Policy; 2010; 8(2):129-40. PubMed ID: 20175591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.